Epigenetic Enzyme Activity Research

Epigenetic Enzyme Activity Research (Learn More about Epigenetics)

Epigenetic modifications participate in cell fate determination, development and disease progression by regulating chromatin states and gene expression. Among these, histone methylation and demethylation represent critical epigenetic regulatory mechanisms. Changes in methylation levels at specific histone sites are closely associated with tumorigenesis, cell proliferation, aberrant gene expression and other biological processes.

Histone Methyltransferases (HMTs) and Histone Demethylases (HDMs) are responsible for establishing and erasing histone methylation marks, respectively. Accordingly, detection of modification status at specific histone sites can be applied to evaluate the activity of relevant epigenetic enzymes and the regulatory effects of candidate compounds on enzyme activity.

Histone Methylation and Demethylation in Epigenetic Regulation. Histone methyltransferases (HMTs) add methyl groups to specific histone residues, whereas histone demethylases (HDMs) remove these modifications, dynamically regulating chromatin states and gene expression. Detection of site-specific histone methylation levels provides a molecular readout for evaluating epigenetic enzyme activity and the effects of candidate compounds on histone modification.

KeyTec® TR-FRET Epigenetic Assay relies on detection of modification status at specific histone sites and provides TR-FRET assay products for epigenetic enzyme activity research and inhibitor screening. Current products include TR-FRET detection antibodies targeting Histone H3K9Me0 and Histone H3K36Me1, which can be used to build corresponding histone modification assay systems.

1 Principle of Histone Modification Status Detection

The KeyTec® TR-FRET epigenetic assay system recognizes modification status at specific sites on histone H3 to analyze changes in histone modification levels during enzymatic reactions.

In the reaction system of histone methyltransferases or histone demethylases, the target enzyme acts on the corresponding histone substrate and alters the methylation status at specific sites. Upon reaction completion, modification-specific TR-FRET detection antibodies are used for recognition. Modification levels at target sites are evaluated based on changes in assay signals, enabling activity analysis of relevant epigenetic enzymes.

Corresponding Histone H3 modification detection products can be selected for different research targets to build assay systems matched to the target enzyme.

2 Detection of Modifications at Specific Histone H3 Sites

KeyTec® provides TR-FRET detection antibodies against various Histone H3 modification states, including Histone H3K9Me0 and Histone H3K36Me1.

The Histone H3K9Me0 TR-FRET Detection Antibody is used to detect the unmethylated state at the H3K9 site, suitable for activity studies of relevant histone methyltransferases/demethylases and evaluation of candidate compounds.

The Histone H3K36Me1 TR-FRET Detection Antibody detects the monomethylated state of H3K36, and can be applied to related histone modification research as well as analysis of epigenetic enzyme activity and regulatory effects.

Specific detection of distinct modification states enables selection of appropriate detection products according to the reaction characteristics of target enzymes, delivering flexible assay solutions for diverse epigenetic research systems.

3 Epigenetic Enzyme Activity and Inhibitor Screening

KeyTec® TR-FRET assay products support epigenetic enzyme activity research and candidate compound evaluation.

In enzyme activity assays, the catalytic activity of histone methyltransferases or demethylases can be analyzed by measuring changes in modification status at specific histone sites. After adding candidate inhibitors or modulators, the impact of compounds on target enzyme activity can be assessed by comparing TR-FRET signals under different treatment conditions.

Further testing of candidate compounds at serial concentrations yields concentration-dependent activity changes, which can be used for dose-response analysis and evaluation of parameters such as IC₅₀, providing experimental evidence for candidate compound screening and potency comparison in epigenetic drug discovery.

4 From Target Research to Compound Evaluation

Epigenetic enzymes generally possess multiple substrates and modification sites, and different assay systems have distinct requirements for detection sites and modification status. By supplying TR-FRET detection antibodies targeting specific sites on Histone H3, we allow researchers to select appropriate assay systems based on target enzymes and research objectives.

The related products can be applied to epigenetic enzyme activity analysis, enzyme inhibitor screening, potency evaluation of candidate compounds and mechanism-of-action studies. In the early stage of drug discovery, compound potency can be compared across multiple compound concentrations and experimental conditions, providing detection tools for subsequent epigenetic target research.

5 KeyTec® Epigenetic Assay Product Portfolio

6 Advantages of KeyTec® TR-FRET Epigenetic Assay Products

- Site-Specific Modification Detection

Detection targeting specific sites and modification states on Histone H3, enabling the setup of diverse histone modification assay systems.

- Support for Epigenetic Enzyme Activity Research

Suitable for activity studies of histone methyltransferases, demethylases and related enzymes, supplying detection tools for research on epigenetic regulatory mechanisms.

- Suitable for Inhibitor Screening

Changes in histone modification status are measured to assess the effects of candidate inhibitors or modulators on the activity of relevant epigenetic enzymes; serial concentration testing and dose-response analysis are supported.

- Drug Discovery-Oriented Applications

Applicable to epigenetic target validation, enzyme activity assays, candidate compound screening, potency comparison and mechanism-of-action research.

- Flexible TR-FRET Assay Solutions

Select matching detection antibodies according to distinct Histone H3 modification states, allowing flexible assembly of epigenetic assay systems based on target enzymes and research requirements.

Centered on detection of modification status at specific Histone H3 sites, KeyTec® TR-FRET Epigenetic Assay provides targeted assay products for epigenetic enzyme activity analysis and candidate compound screening, facilitating research on histone modification mechanisms and epigenetic drug discovery.

Explore Products | Get Technical Support | Custom TR-FRET Assay